Sign in

CIK 0000805928

  • Large accelerated filer

Axogen, Inc.

Sign in to watch
Ticker
AXGN
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
MN
Entity type
Operating
EIN
411301878
Phone
+1 386-462-6817
Business address
13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
Former names
LECTEC CORP /MN/
  1. 4 Shares withheld for taxes Chief R&D Officer gave up 2,770 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Commercial Officer gave up 1,512 shares (to pay taxes)
  3. 4 Shares withheld for taxes General Counsel and CCO gave up 648 shares (to pay taxes)
  4. 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 2,769 shares (to pay taxes)
  5. 4 Shares withheld for taxes VP Regulatory Affairs & Policy gave up 1,502 shares (to pay taxes)
  6. 4 Shares withheld for taxes VP Operations gave up 1,512 shares (to pay taxes)
  7. 4 Shares withheld for taxes VP Peripheral Nerve Science gave up 1,497 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Strategy and BD Officer gave up 2,447 shares (to pay taxes)
  9. 4 Option exercise VP Operations acquired 15,000 shares (option exercise)
  10. 4 Grant or award CEO acquired 13,978 shares (grant or award)
  11. 4 Shares withheld for taxes Chief Commercial Officer gave up 762 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief R&D Officer gave up 400 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Human Resources Officer gave up 400 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 950 shares (to pay taxes)
  15. 4 Shares withheld for taxes VP Regulatory Affairs & Policy gave up 357 shares (to pay taxes)
  16. 4 Shares withheld for taxes VP Operations gave up 205 shares (to pay taxes)
  17. 4 Shares withheld for taxes VP Peripheral Nerve Science gave up 357 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Strategy and BD Officer gave up 447 shares (to pay taxes)
  19. 4 Shares withheld for taxes CEO gave up 1,752 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief R&D Officer gave up 286 shares (to pay taxes)

Page 11 of 36 · 705 filings